SS

Suruchi Shrivastava

Active Director Director DIN 10895723
DIN 10895723 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Suruchi Shrivastava

Data last updated:

Suruchi Shrivastava is a Director at Medhoc Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 10895723
Primary Designation Director
Industry Pharma
First Appointment 03 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jan 20252025Active

Board colleagues of Suruchi Shrivastava

NameDINCompanyDesignation
Piyush Shrivastava09292719Medhoc Pharmaceuticals Private LimitedIndividual Subscriber
Sapna Hota10895722Medhoc Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medhoc Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Suruchi Shrivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suruchi Shrivastava

Suruchi Shrivastava currently holds 1 directorship: Medhoc Pharmaceuticals Private Limited (Director, since 03 Jan 2025).

Suruchi Shrivastava was first appointed on 03 Jan 2025 as Director at Medhoc Pharmaceuticals Private Limited.

The current boards of Suruchi Shrivastava's companies include Piyush Shrivastava (Medhoc Pharmaceuticals Private Limited), Sapna Hota (Medhoc Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available